SANA Sana Biotechnology, Inc.
Healthcare$3.07-2.54%ClosedMarket Cap: $854.4M
As of 2026-05-25
Valuation
P/E (TTM)
—
PEG
—
P/B
7.13
P/S
0.00
EV/EBITDA
-4.70
DCF Value
$-0.03
FCF Yield
-15.6%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-161.9%
ROA
-64.8%
ROIC
-78.6%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $0.00 | -Infinity% | $-37.9M | $-47.2M | $— | — |
| Q4 null | $0.00 | NaN% | $-61.2M | $-58.8M | $— | — |
| FY null | $0.00 | -Infinity% | $-191.0M | $-244.2M | $— | — |
| Q3 null | $0.00 | NaN% | $-43.5M | $-42.2M | $— | — |
| Q2 null | $0.00 | NaN% | $-95.0M | $-93.8M | $— | — |
| Q1 null | $0.00 | NaN% | $-50.6M | $-49.4M | $— | — |
| Q4 null | $0.00 | NaN% | $-50.9M | $-49.1M | $— | — |
| FY null | $0.00 | NaN% | $-272.7M | $-266.8M | $— | — |
| Q3 null | $0.00 | NaN% | $-61.8M | $-59.9M | $— | — |
| Q2 null | $0.00 | NaN% | $-49.4M | $-50.3M | $— | — |
| Q1 null | $0.00 | NaN% | $-110.7M | $-107.5M | $— | — |
| Q4 2023 | $0.00 | NaN% | $-90.6M | $-88.1M | $-0.45 | — |